Cargando…

Warm-blood cardioplegia with low or high magnesium for coronary bypass surgery: a randomised controlled trial()

Objective: Magnesium (Mg(2+)) is cardioprotective and has been routinely used to supplement cardioplegic solutions during coronary artery bypass graft (CABG) surgery. However, there is no consensus about the Mg(2+) concentration that should be used. The aim of this study was to compare the effects o...

Descripción completa

Detalles Bibliográficos
Autores principales: Caputo, Massimo, Santo, Kirkpatrick C., Angelini, Gianni D., Fino, Carlo, Agostini, Marco, Grossi, Claudio, Suleiman, M.-Saadeh, Reeves, Barnaby C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162136/
https://www.ncbi.nlm.nih.gov/pubmed/21353585
http://dx.doi.org/10.1016/j.ejcts.2010.09.049
_version_ 1782210786420064256
author Caputo, Massimo
Santo, Kirkpatrick C.
Angelini, Gianni D.
Fino, Carlo
Agostini, Marco
Grossi, Claudio
Suleiman, M.-Saadeh
Reeves, Barnaby C.
author_facet Caputo, Massimo
Santo, Kirkpatrick C.
Angelini, Gianni D.
Fino, Carlo
Agostini, Marco
Grossi, Claudio
Suleiman, M.-Saadeh
Reeves, Barnaby C.
author_sort Caputo, Massimo
collection PubMed
description Objective: Magnesium (Mg(2+)) is cardioprotective and has been routinely used to supplement cardioplegic solutions during coronary artery bypass graft (CABG) surgery. However, there is no consensus about the Mg(2+) concentration that should be used. The aim of this study was to compare the effects of intermittent antegrade warm-blood cardioplegia supplemented with either low- or high-concentration Mg(2+). Methods: This study was a randomised controlled trial carried out in two cardiac surgery centres, Bristol, UK and Cuneo, Italy. Patients undergoing isolated CABG with cardiopulmonary bypass were eligible. Patients were randomised to receive warm-blood cardioplegia supplemented with 5 or 16 mmol l(−1) Mg(2+). The primary outcome was postoperative atrial fibrillation. Secondary outcomes were serum biochemical markers (troponin I, Mg(2+), potassium, lactate and creatinine) and time-to-plegia arrest. Intra-operative and postoperative clinical outcomes were also recorded. Results: Data from two centres for 691 patients (342 low and 349 high Mg(2+)) were analysed. Baseline characteristics were similar for both groups. There was no significant difference in the frequency of postoperative atrial fibrillation in the high (32.8%) and low (32.0%) groups (risk ratio 1.03, 95% confidence interval, CI, 0.82–1.28). However, compared with the low group, troponin I release was 28% less (95% CI 55–94%, p = 0.02) in the high-Mg(2+) group. The 30-day mortality was 0.72% (n = 5); all deaths occurred in the high-Mg(2+) group but there was no significant difference between the groups (p = 0.06). Frequencies of other major complications were similar in the two groups. Conclusions: Warm-blood cardioplegia supplemented with 16 mmol l(−1) Mg(2+), compared with 5 mmol l(−1) Mg(2+), does not reduce the frequency of postoperative atrial fibrillation in patients undergoing CABG but may reduce cardiac injury. (This trial was registered as ISRCTN95530505.)
format Online
Article
Text
id pubmed-3162136
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-31621362011-10-04 Warm-blood cardioplegia with low or high magnesium for coronary bypass surgery: a randomised controlled trial() Caputo, Massimo Santo, Kirkpatrick C. Angelini, Gianni D. Fino, Carlo Agostini, Marco Grossi, Claudio Suleiman, M.-Saadeh Reeves, Barnaby C. Eur J Cardiothorac Surg Article Objective: Magnesium (Mg(2+)) is cardioprotective and has been routinely used to supplement cardioplegic solutions during coronary artery bypass graft (CABG) surgery. However, there is no consensus about the Mg(2+) concentration that should be used. The aim of this study was to compare the effects of intermittent antegrade warm-blood cardioplegia supplemented with either low- or high-concentration Mg(2+). Methods: This study was a randomised controlled trial carried out in two cardiac surgery centres, Bristol, UK and Cuneo, Italy. Patients undergoing isolated CABG with cardiopulmonary bypass were eligible. Patients were randomised to receive warm-blood cardioplegia supplemented with 5 or 16 mmol l(−1) Mg(2+). The primary outcome was postoperative atrial fibrillation. Secondary outcomes were serum biochemical markers (troponin I, Mg(2+), potassium, lactate and creatinine) and time-to-plegia arrest. Intra-operative and postoperative clinical outcomes were also recorded. Results: Data from two centres for 691 patients (342 low and 349 high Mg(2+)) were analysed. Baseline characteristics were similar for both groups. There was no significant difference in the frequency of postoperative atrial fibrillation in the high (32.8%) and low (32.0%) groups (risk ratio 1.03, 95% confidence interval, CI, 0.82–1.28). However, compared with the low group, troponin I release was 28% less (95% CI 55–94%, p = 0.02) in the high-Mg(2+) group. The 30-day mortality was 0.72% (n = 5); all deaths occurred in the high-Mg(2+) group but there was no significant difference between the groups (p = 0.06). Frequencies of other major complications were similar in the two groups. Conclusions: Warm-blood cardioplegia supplemented with 16 mmol l(−1) Mg(2+), compared with 5 mmol l(−1) Mg(2+), does not reduce the frequency of postoperative atrial fibrillation in patients undergoing CABG but may reduce cardiac injury. (This trial was registered as ISRCTN95530505.) Oxford University Press 2011-09 /pmc/articles/PMC3162136/ /pubmed/21353585 http://dx.doi.org/10.1016/j.ejcts.2010.09.049 Text en © 2011 Elsevier B.V. This document may be redistributed and reused, subject to certain conditions (http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0) .
spellingShingle Article
Caputo, Massimo
Santo, Kirkpatrick C.
Angelini, Gianni D.
Fino, Carlo
Agostini, Marco
Grossi, Claudio
Suleiman, M.-Saadeh
Reeves, Barnaby C.
Warm-blood cardioplegia with low or high magnesium for coronary bypass surgery: a randomised controlled trial()
title Warm-blood cardioplegia with low or high magnesium for coronary bypass surgery: a randomised controlled trial()
title_full Warm-blood cardioplegia with low or high magnesium for coronary bypass surgery: a randomised controlled trial()
title_fullStr Warm-blood cardioplegia with low or high magnesium for coronary bypass surgery: a randomised controlled trial()
title_full_unstemmed Warm-blood cardioplegia with low or high magnesium for coronary bypass surgery: a randomised controlled trial()
title_short Warm-blood cardioplegia with low or high magnesium for coronary bypass surgery: a randomised controlled trial()
title_sort warm-blood cardioplegia with low or high magnesium for coronary bypass surgery: a randomised controlled trial()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162136/
https://www.ncbi.nlm.nih.gov/pubmed/21353585
http://dx.doi.org/10.1016/j.ejcts.2010.09.049
work_keys_str_mv AT caputomassimo warmbloodcardioplegiawithloworhighmagnesiumforcoronarybypasssurgeryarandomisedcontrolledtrial
AT santokirkpatrickc warmbloodcardioplegiawithloworhighmagnesiumforcoronarybypasssurgeryarandomisedcontrolledtrial
AT angelinigiannid warmbloodcardioplegiawithloworhighmagnesiumforcoronarybypasssurgeryarandomisedcontrolledtrial
AT finocarlo warmbloodcardioplegiawithloworhighmagnesiumforcoronarybypasssurgeryarandomisedcontrolledtrial
AT agostinimarco warmbloodcardioplegiawithloworhighmagnesiumforcoronarybypasssurgeryarandomisedcontrolledtrial
AT grossiclaudio warmbloodcardioplegiawithloworhighmagnesiumforcoronarybypasssurgeryarandomisedcontrolledtrial
AT suleimanmsaadeh warmbloodcardioplegiawithloworhighmagnesiumforcoronarybypasssurgeryarandomisedcontrolledtrial
AT reevesbarnabyc warmbloodcardioplegiawithloworhighmagnesiumforcoronarybypasssurgeryarandomisedcontrolledtrial